Our observation of enhanced expression of CD11b in OG-86-cultured KD cells raised a question as to whether concomitant pharmacologic targeting of mTORC1 and LSD1 might collaborate to further induce a molecular differentiation programme in AML cells. Here, KDM1A is linked to acute myeloid leukemia.